Investor Relations
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications.
Latest News
NEXGEL Appoints Kip Crecca to its Scientific Advisory Board
NEXGEL's Beauty Brand, Silly George, Partners with Multi-Talented Artist and Entrepreneur, James Maslow, to Promote Innovative Eyelash Collection
Latest Financial Results
Q2 2024
Quarter Ended Jun 30, 2024
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2023
Report Links
Company Overview
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.
IR Contacts
Headquarters
NEXGEL, Inc.
2150 Cabot Boulevard West
Suite B
Langhorne, PA 19407
T: 215-702-8550
info@nexgel.com
Investor Relations
KCSA Strategic Communications
T: 212-896-1254
Valter Pinto
valter@kcsa.com
Nick Staab
nstaab@kcsa.com
Transfer Agent
Continental Stock Transfer & Trust Company
1 State Street
30th Floor
New York, NY 10004
T: 212-845-3269
Legal Counsel
Quick Law Group P.C.
1035 Pearl Street
Suite 403
Boulder, CO 80302
T: 720-259-3393